By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ORIENT BIO Inc.

ORIENT BIO Inc. (002630.KS)

KSC Currency in KRW
₩642.00
-₩8.00
-1.23%
Last Update: 10 Sept 2025, 06:30
₩76.12B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
₩408.00 - ₩2.56K
52 Week Range

002630.KS Stock Price Chart

Explore ORIENT BIO Inc. interactive price chart. Choose custom timeframes to analyze 002630.KS price movements and trends.

002630.KS Company Profile

Discover essential business fundamentals and corporate details for ORIENT BIO Inc. (002630.KS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

4 Jan 2000

Employees

125.00

CEO

Jae-Jin Chang

Description

ORIENT BIO Inc. operates in the bio-industry in South Korea. The company produces laboratory animals. In addition, it offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam, South Korea.

002630.KS Financial Timeline

Browse a chronological timeline of ORIENT BIO Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Dec 2024

EPS came in at -₩11.00 , while revenue for the quarter reached ₩8.96B .

Earnings released on 30 Sept 2024

EPS came in at -₩9.00 , while revenue for the quarter reached ₩6.73B .

Earnings released on 29 Jun 2024

EPS came in at -₩57.22 , while revenue for the quarter reached ₩7.38B .

Earnings released on 27 Jun 2024

EPS came in at ₩1.80 , while revenue for the quarter reached ₩8.18B .

Earnings released on 30 Mar 2024

EPS came in at ₩55.08 , while revenue for the quarter reached ₩5.96B .

Earnings released on 30 Sept 2023

EPS came in at -₩5.48 , while revenue for the quarter reached ₩6.41B .

Earnings released on 30 Jun 2023

EPS came in at ₩19.54 , while revenue for the quarter reached ₩7.02B .

Earnings released on 31 Mar 2023

EPS came in at ₩4.31 , while revenue for the quarter reached ₩5.96B .

Earnings released on 14 Feb 2023

EPS came in at ₩73.27 , while revenue for the quarter reached ₩7.77B .

Earnings released on 31 Dec 2022

EPS came in at -₩107.11 , while revenue for the quarter reached ₩8.07B .

Earnings released on 30 Jun 2022

EPS came in at -₩75.00 , while revenue for the quarter reached ₩7.02B .

Earnings released on 31 Dec 2021

EPS came in at ₩7.93 , while revenue for the quarter reached ₩17.21B .

Earnings released on 30 Sept 2021

EPS came in at -₩1.86 , while revenue for the quarter reached ₩14.48B .

Earnings released on 30 Jun 2021

EPS came in at ₩22.69 , while revenue for the quarter reached ₩13.50B .

Earnings released on 31 Mar 2021

EPS came in at -₩87.54 , while revenue for the quarter reached ₩13.90B .

Earnings released on 31 Dec 2020

EPS came in at ₩34.00 , while revenue for the quarter reached ₩14.13B .

Earnings released on 30 Sept 2020

EPS came in at -₩81.00 , while revenue for the quarter reached ₩12.02B .

002630.KS Stock Performance

Access detailed 002630.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run